Mar 30, 2020

In this episode, Stacey Richter talks with Marty Makary, MD, MPH, surgeon at Johns Hopkins and author of “The Price We Pay,” about action steps for hospitals, payers, employers, and pharma from now until June, during the reactive phase of the COVID-19 pandemic. Episode 267.

WHAT YOU’LL LEARN

✅ What made Marty...

Mar 26, 2020

In this episode, recorded prior to COVID-19 hitting the US, Stacey Richter talks with Matt Anderson, MD, MBA, innovation lead at Banner Health, about why partnership between “scrubs” and “suits” leads to better outcomes for everyone except those looking to exploit patients.

WHAT YOU’LL LEARN

✅ Why physician...

Mar 19, 2020

In this episode, Stacey Richter talks with Randy Vogenberg, PhD, principal at the Institute for Integrated Healthcare, about the what, the how, and the questionable why of digital therapeutic formularies.

WHAT YOU’LL LEARN

✅ What a digital formulary actually is, and why PBMs are drawn to creating them

✅ Why the...

Mar 12, 2020

In this episode, Stacey Richter talks with Ron Wince, CEO of Myndshft, about how prior authorizations collide with trust between payers and providers.

WHAT YOU’LL LEARN

✅ Why payers put prior authorizations in place, and the three reasons behind them: cost, medical necessity, and compliance

✅ How the prior...

Mar 5, 2020

In this episode, Stacey Richter talks with Andrew Eye, CEO of ClosedLoop, about how population health leaders are actually using artificial intelligence right now.

WHAT YOU’LL LEARN

✅ How top-performing Medicare Advantage plans are already using AI to risk-stratify populations

✅ What predictive analytics actually...